 |
 |
Mystery virus slow to yield its identity as patient numbers rise.
The virus causing the pneumonia-like outbreak of severe acute respiratory syndrome is continuing to perplex researchers.
28 March 2003 |
|
 |
|
Battle of the mind
Plans for an Alzheimer's disease vaccine could be about to get back on track.
28 March 2003 |
|
 |
|
News in Brief
Chemotherapy nausea drug gets FDA approval | FDA approval for pegvisomant | Two HIV vaccines better than one | Gleevec mechanism in rare cancer revealed
28 March 2003 |
|
 |
|
Health labs focus on mystery pneumonia
The World Health Organization is co-ordinating a major international investigation to identity the cause of a new pneumonia-like disease that represents "a worldwide health threat".
21 March 2003 |
|
 |
|
News in brief
Antisense lung cancer drug fails Phase III trial | Novartis' purchase of Pfizer drug clears merger barrier | Jury finds Bayer not liable in Baycol suit | Fuzeon Phase III trial results published.
21 March 2003 |
|
 |
|
Tougher rules aim to prevent geneflow into crops
Trials using 'Pharma crops' - genetically modified corn that produces pharmaceuticals - face tight regulations.
14 March 2003 |
|
 |
|
News in brief
Monoclonal antibody could treat peanut allergy | Statin Crstor receives European setback | Bristol-Myers-Squibb restate earnings | Further Baycol woes for Bayer
14 March 2003 |
|
 |
|
Cancer risk prompts US to curb gene therapy
Not all trials using gene therapy should be halted, says an FDA advisory panel.
7 March 2003 |
|
 |
|
News in brief
GSK loses patent case on best-selling drug | FDA assesses risks of arthritis drugs | Industry wins COX-2 patent case | Best selling drugs and therapeutic classes in 2003 revealed
7 March 2003 |
